You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

childhood acute myeloid leukemia in remission

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • B7-H3 target, CAR gene modified gdT cell injection
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital， Zhejiang University School of Med
Feb 15, 2023

Acute Myeloid Leukemia Trial in Taipei

Enrolling by invitation
  • Acute Myeloid Leukemia
    • Taipei, Taiwan
      National Taiwan University Hospital
    Aug 9, 2023

    Acute Myeloid Leukemia Trial in Worldwide (Cyclophosphamide-Fludarabine (Cy/Flu), oNKord®)

    Recruiting
    • Acute Myeloid Leukemia
    • Cyclophosphamide-Fludarabine (Cy/Flu)
    • oNKord®
    • Ghent, Belgium
    • +9 more
    Jun 15, 2022

    Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

    Not yet recruiting
    • Chronic Myeloid Leukemia, BCR/ABL-Positive
      • Taipei, Taiwan
        National Taiwan University Hospital
      Jul 24, 2022

      Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Minimal Residual Disease
        • Chapel Hill, North Carolina
          North Carolina Cancer Hospital (NCCH)
        Feb 2, 2023

        Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

        Active, not recruiting
        • Acute Myeloid Leukemia
        • +5 more
        • Duarte, California
          City of Hope Medical Center
        Jan 4, 2023

        Acute Myeloid Leukemia Trial in Los Angeles, San Francisco (Azacitidine, Tagraxofusp-erzs)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Los Angeles, California
        • +1 more
        Jan 31, 2023

        MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

        Recruiting
        • Myelodysplastic Syndromes, de Novo
        • +10 more
        • Boston, Massachusetts
          Dana-Farber Cancer Institute
        Jan 23, 2023

        AML, Childhood Trial in United States (Nivolumab, 5-azacytidine)

        Active, not recruiting
        • AML, Childhood
        • Los Angeles, California
        • +11 more
        Oct 10, 2022

        Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,

        Recruiting
        • Acute Myeloid Leukemia
        • +2 more
        • Miami, Florida
          University of Miami
        Dec 22, 2022

        Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

        Recruiting
        • Relapsed or Refractory Acute Myeloid Leukemia
        • Taiyuan, Shanxi, China
          Tao Wang
        Feb 9, 2023

        Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

        Recruiting
        • Acute Myeloid Leukemia
        • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
        • "3+7"
        • Beijing, Beijing, China
          Chinese PLA General Hospital
        Sep 29, 2023

        Tumor Tissue Samples From Young Acute Lymphoblastic Leukemia

        Completed
        • Childhood Acute Lymphoblastic Leukemia in Remission
        • Recurrent Childhood Acute Lymphoblastic Leukemia
        • Laboratory Biomarker Analysis
        • Philadelphia, Pennsylvania
          Childrens Oncology Group
        Aug 12, 2022

        Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

        Recruiting
        • Acute Myeloid Leukemia, Adult
        • cladribine + homoharringtonine + cytarabine
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital, Zhejiang University School of Med
        Jun 13, 2023

        Acute Myeloid Leukemia Trial in Houston (ASTX727, ASTX029-01)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Houston, Texas
          MD Anderson Cancer Center
        Oct 27, 2023

        Acute Myeloid Leukemia Trial in Kunming (CLL1 and CD38 dual-target CAR-T injection)

        Recruiting
        • Acute Myeloid Leukemia
        • CLL1 and CD38 dual-target CAR-T injection
        • Kunming, Yunnan, China
          920th Hospital of Joint LogisticsSupport Force of People's Liber
        Oct 26, 2023

        Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • High-Risk and Very High-Risk Myelodysplastic Syndromes
        • (no location specified)
        Jul 25, 2023

        Acute Myeloid Leukemia Trial (NK cells, Talazoparib 1 MG [Talzenna])

        Not yet recruiting
        • Acute Myeloid Leukemia
        • NK cells
        • Talazoparib 1 MG [Talzenna]
        • (no location specified)
        Jan 9, 2023

        Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

        Recruiting
        • Acute Myeloid Leukemia
        • +4 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 27, 2023

        Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

        Suspended
        • Juvenile Myelomonocytic Leukemia
        • +27 more
        • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
        • +2 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Jan 11, 2023

        iN the Real Practice

        Not yet recruiting
        • Acute Myeloid Leukemia (AML)
        • +2 more
        • Vyxeos liposomal
        • Roma, Italy
          Policlinico Tor Vergata
        Nov 16, 2023

        Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing

        Recruiting
        • Relapsed/Refractory Acute Myeloid Leukemia
        • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
        • Best-Available Therapy(BAT) Regimen
        • Beijing, Beijing, China
          Chinese PLA General Hospital
        Oct 10, 2023

        GilteRInf 2022 Study (Gilteritinib Related Infections)

        Active, not recruiting
        • Acute Myeloid Leukemia
        • Roma, RM, Italy
          Maria Ilaria Del Principe
        Mar 17, 2023

        Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)

        Recruiting
        • Acute Myeloid Leukemia
        • Beijing, Beijing, China
          Chinese PLA General Hospital
        Dec 13, 2022

        Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

        Not yet recruiting
        • Acute Lymphoblastic Leukemia
        • +6 more
        • Miltenyi CliniMACS Prodigy ® system
        • (no location specified)
        Mar 23, 2023